Ambròs, R.D. et al. 2021. Efficacy and safety of intranasal haloperidol in an acute Psychiatry Unit: a pilot study on schizophrenic patients with mild-modedate agitation. Actas Españolas de Psiquiatría. 49, 5 (Sep. 2021), 205–209.